JSW Dulux — a 70-year-old company, four months old
JSW Dulux (formerly Akzo Nobel India Limited)
JSW Dulux — a 70-year-old company, four months old
On the morning of December 10, 2025, in offices several thousand miles apart, a set of documents got countersigned and a 70-year-old Indian paint company changed hands. AkzoNobel NV, the Dutch coatings giant whose Indian liquid-paints arm had been one of the steadier dividend-paying franchises on the BSE for two decades, transferred 60.76% of Akzo Nobel India Limited to JSW Group for Rs 8,986 crore in cash. Three months later, on March 11, 2026, the listco’s name on the bourses changed from AKZOINDIA to JSWDULUX. The board reorganised. Parth Jindal — Sajjan Jindal’s son, the operator who has been running the family’s paint ambitions since 2019 — took over as Non-Executive Chairman. Rajiv Rajgopal, the CEO who had been with the AkzoNobel system in India for years, stayed on as Joint MD. The Dulux brand on the cans stayed; the parent that owned that brand, internationally, did not.
So the company has, depending on how you count, either seven decades of history in India or about four months. Both are true. And the gap between those two ways of counting is the entire analytical problem with this stock.
What the old company was, before any of this
For something close to twenty quiet years, Akzo Nobel India ran a small and very profitable book. Decorative paints under the Dulux brand sat at the heart of it — premium positioning, urban-skewed dealer network, the kind of business that doesn’t double in three years but throws off cash like a loyal annuity. EBITDA margins parked themselves in the 13-14% band, ROE in the 30s, ROCE in the 40s, almost no debt on the balance sheet, and a dividend payout ratio that in a normal year sat north of 100% — meaning the Dutch parent took out more than the Indian subsidiary earned, which it could afford to do because the cash kept arriving anyway. Boring in the good way. Around it sat a Powder Coatings business — a B2B industrial line serving auto, white goods and architectural extrusion customers from a Gwalior plant, ~5,200 tonnes of annual capacity, Rs 421 cr of FY25 revenue — and an International Research Centre in Bangalore that cost-plus-billed back to the AkzoNobel global system, contributing Rs 53.5 cr of FY25 revenue and roughly nil margin. Together, the two non-decorative pieces accounted for about 12% of the listco’s top line. The rest — close to Rs 3,617 cr of FY25 revenue if you strip them out — was the decorative-and-allied business that JSW would eventually pay for.
It was also, in February 2025, the moment when AkzoNobel NV in the Netherlands announced it was selling. The Dutch parent had been under European-divestment pressure — a portfolio rationalisation programme that the new CEO had been signalling for some time — and India, for all its profitability, was a sub-scale geography in a global coatings business. The decision to exit landed in the same window in which JSW Group, having spent six years building a paints business from scratch, had reached the point of needing to acquire its way to scale. Two timelines met.
The transaction, walked through as it happened
The structure JSW agreed to was not a clean buy-the-listco deal. It was, deliberately, a carve-out and a sale rolled into one. AkzoNobel NV wanted to keep the Powder Coatings business — a more globally fungible asset that fit into its remaining portfolio — and it wanted to keep the brand IP. The Indian listco was therefore restructured before the buyer arrived.
In the slump-sale agreements signed February 2025, three things were transferred from the listed entity to AkzoNobel NV. The Powder Coatings business went for Rs 2,073 cr. The International Research Centre went for Rs 70 cr. And the brand intellectual property for Dulux, Weathershield and the rest of the decorative portfolio — for the geographies of India, Bangladesh, Bhutan and Nepal — was transferred to the Dutch parent for Rs 1,152 cr, with a reciprocal long-term licensing arrangement for the Indian listco to continue using those brands inside South Asia. Total consideration to the listco from the slump sale: Rs 3,295 cr. Of which a substantial chunk, Rs 167.5 per share, came back out as a special interim dividend in late 2025 — and because AkzoNobel NV at that point still held about 75% of the listco through Imperial Chemical Industries (50.46%) and Akzo Nobel Coatings International (24.30%), roughly 62% of that dividend distribution flowed to the same Dutch parent that had just been paid for the carve-out. Public shareholders received the dividend pari passu, which was the polite phrase for “small consolation.”
The main event came in June 2025, when JSW Paints Limited — a privately-held entity inside JSW Group — signed the Share Purchase Agreement to acquire AkzoNobel NV’s residual 74.76% stake in the listed company at Rs 8,986 cr. JTPM Metal Traders and JSW EduInfra were named as Persons Acting in Concert. The implied per-share price worked out to Rs 3,248. The deal was announced on a 25x trailing EV/EBITDA multiple — restated upward from the 22x at first announcement as the carved-out continuing business saw EBITDA soften in the run-up to close. Enterprise value on a 100% equity basis: roughly Rs 14,790 cr.
The Competition Commission of India cleared the transaction on September 16, 2025, on standard terms. The PIB note approved acquisition of “up to 75% shareholding” with no behavioural remedies — no pricing constraint, no dealer-overlap divestment, no structural condition that would constrain JSW’s freedom to operate the combined entity later. Detailed reasoning will follow in the gazette publication in time, but as of the public order, the regulator did not see the kind of horizontal-overlap problem that would have required surgery on the deal. The clearance was clean.
The mandatory open offer for an additional 25.24% — the SEBI Substantial Acquisition floor that gets triggered well before 60% — opened October 23, 2025 and closed November 6, 2025. The offer price was set at Rs 3,231.77 per share, adjusted downward from an initial Rs 3,417.77 because the interim-dividend record date fell inside the offer window. Subscription was light: only 0.44% of the equity got tendered, taking JSW from the 60.76% they had bought in the SPA to 61.20% post-offer. AkzoNobel NV, which had agreed to sell 74.76% but ran into the JSW acquirer being capped at 75% under the SEBI regime, ended up retaining 14.0% as a residual passive holder. The light open-offer subscription mattered less for what JSW ended up with and more for what it told you about the public shareholders — at Rs 3,231 against a market price in the high Rs 2,800s and an open-ended visibility reset ahead of FY27, most of them sat tight. Some were waiting for a higher offer down the line. The more probable explanation is that they preferred the optionality of riding alongside JSW into a future merger or buyout to the cash exit at close-to-market price.
December 10, 2025: the deal closed. AkzoNobel NV in its own announcement told the market that of the net €1.4bn enterprise-value proceeds, about €500m would go to deleveraging and €400m to a buyback at the parent level — the kind of capital-return choreography that European holding companies do as a matter of course when they exit a sub-scale geography. The Indian listco sat there, now under a new majority shareholder, still trading under AKZOINDIA, the rebrand approval still working its way through the system. Board approval came on January 28, 2026, postal-ballot approval through February, MCA sign-off in March 2026. On March 11, 2026, AKZOINDIA became JSWDULUX. A 70-year-old paint company became, on the ticker tape and in the SEBI filings, four months old.
The buyer: who Sajjan Jindal is, when he buys things
JSW Group is a $30bn-revenue conglomerate, give or take, with the centre of gravity in steel. JSW Steel is the family jewel — over 35 million tonnes per annum of capacity, built up over two decades from the Vijayanagar integrated complex in Karnataka and scaled aggressively from the late 1990s onward. The Bhushan Power & Steel acquisition was a multi-year legal grind; the JFE Steel JV announced April 2026 added a Rs 32,000 cr Odisha expansion to the pipeline. ROCE and EBITDA-per-tonne have been respectable through the cycle without ever quite making JSW Steel the structural premium player that Tata Steel was. JSW Energy followed a familiar pattern — thermal-and-hydro through 2020, then an aggressive renewables pivot, financed with leverage that was acceptable rather than conservative. JSW Cement, listed in October 2025, came out of the steel business through slag integration, and has been growing through acquisition into a credible #4-5 in a commoditised industry. The pattern across all of these is the same one: Sajjan Jindal builds patient scale in industries where the market structure rewards low-cost, deep-capital, integrated manufacturing. He is one of the better operators of that template in Indian industry. He is not a brand operator. He is not a distribution operator. The companies he has built do not have moats that depend on customer pull.
Whether that template translates to a brand-and-distribution business like decorative paints is the open question that hangs over JSWDULUX and that no one — including Sajjan and Parth Jindal themselves, almost certainly — yet knows the answer to.
The most useful evidence of what JSW will do with Dulux is what JSW has already done with paints. In May 2019, the family set up JSW Paints as a privately-held standalone vehicle, with an initial Rs 600 cr of capitalisation — roughly Rs 250 cr of equity and Rs 350 cr of debt from Axis Bank. The brand was new, the manufacturing footprint was new, the dealer network had to be built from zero. By FY24 — five years in — the standalone vehicle had reached Rs 2,000-2,200 cr of revenue and had achieved its first year of operating breakeven, with EBITDA margins of about 3% (~Rs 67 cr). Then in FY25, two things happened in the same year: the broader paint sector entered the worst margin reset in recent memory as Birla landed with several thousand crores of marketing spend, and JSW Paints’ growth collapsed. FY25 revenue printed Rs 2,150 cr — only 2.5% higher than FY24. CARE Ratings, in a July 2025 press release, noted that operating losses returned in FY25 because of pricing pressure and elevated overheads on the marketing and employee lines. The breakeven of FY24 didn’t sustain. The original target — set in early 2024, of Rs 5,000 cr revenue by FY26 — was, on the FY25 trajectory, no longer in sight. FY26 will more likely print Rs 2,500-3,000 cr at organic growth rates. Pre-deal, JSW Paints standalone had a mid-single-digit (3-4%) market share. Adding Akzo’s pre-deal ~7% gets you to about 10-11% combined.
This is the cautionary detail that hangs over everything else. Six years post-launch, JSW’s standalone paint business has not sustained breakeven, has missed half of its own FY26 revenue target, and saw growth fall to single digits just as the competitive intensity from Birla landed. That is a more sobering starting point than the JSW-Group conglomerate narrative implies. The premium-urban half of the dual-brand strategy — Dulux, in the listco — inherits a profitable but slow-growing brand. The value half — JSW Paints in Tier-2/3 — sits in a vehicle that has not yet shown that its unit economics work. Putting them together creates scale; whether it creates margin is unproven.
Parth Jindal as the operator, and what the dual-brand pitch actually says
If you read Parth Jindal’s interviews from late 2025 onward — most prominently the Business Standard piece from July 2025 in which he called the merger of JSW Paints Private into the listco “natural” — the strategic logic is clear and, on its own terms, sensible. Dulux stays where it is in the premium urban tier. JSW Paints stays where it is in value Tier-2/3. The two brand identities remain separate, the two distribution networks remain separate, and the combined operation targets Rs 10,000 cr of revenue in three years and the #3 spot in Indian paints by market share. Implied combined revenue CAGR off a FY26 base of Rs 5,800-6,200 cr: roughly 25%. The growth focus is productivity per dealer rather than dealer count. Akzo’s existing footprint of about 22,000 outlets is far below Berger’s 70,000+ and Asian’s 150,000+, but the urban-premium mix means each Akzo dealer transacts higher-value SKUs. Industrial coatings, where Birla has not entered, becomes a stated growth lane. And profitability is targeted from day one — explicitly contrasted with Birla’s cash burn.
The honest read on this last point is that “profitable from day one” is less a strategic choice and more a balance-sheet constraint dressed as discipline. JSW does not have a Grasim-equivalent waiting in the holding-company structure to subsidise multi-year customer-acquisition losses. JSW Paints private was capitalised at Rs 600 cr at founding, and the deal financing for the AkzoNobel acquisition happened at the JSW Paints parent level, not inside the listco. The combined operating book has to pay for itself. That is genuinely a sound strategic posture in a sector that has just demonstrated, courtesy of Birla, what unbounded marketing spend does to industry margins. But the productivity-per-dealer pitch demands execution capabilities — sales-force quality, premium-tier brand maintenance, urban-property dealership economics — that JSW Paints standalone has not yet demonstrated in its six-year history. Dulux’s existing strengths in those areas are inherited, not earned. There is also an implicit assumption that JSW won’t dilute Dulux’s premium positioning while pushing volume — and the temptation to dilute, given the JSW DNA of low-cost scale, will be permanent.
The Rs 10,000 cr / #3 / three-year target should be read as JSW’s stretch case. The base case is probably Rs 7,500-8,500 cr of combined revenue by FY29 and a #4 finish behind Asian, Berger and Birla. The narrower question — whether the listed Dulux entity, which is the only thing public investors actually own, gets to Rs 4,500-5,000 cr from its current Rs 3,617 cr base by FY29 — requires only 6-8% organic CAGR. That, in line with sector growth, is the easier yes. The harder questions are about the value-tier vehicle and the swap ratio.
What the listed entity now actually contains
The pro-forma post-carveout listco is a Rs 3,617 cr FY25-revenue business. The arithmetic is simple: the reported consolidated FY25 number was Rs 4,091.2 cr; subtract Rs 421.2 cr of Powder Coatings and Rs 53.5 cr of IRC, and you arrive at the continuing business. That continuing business is essentially decorative paints under the licensed Dulux brand, plus liquid industrial coatings (the non-powder pieces), plus auto refinish — a mix that is now structurally heavier on decorative than the legacy print suggested, perhaps 88-92% decorative against the pre-carveout 75-80%. The margin profile is harder to model cleanly because the carve-out cuts unevenly. Powder Coatings ran at lower margins than decorative; the IRC was margin-neutral. The most defensible working assumption is that the continuing entity’s structural EBITDA margin is in the mid-13s to low-14s — broadly the same as the consolidated FY25 print of 13.6%, perhaps marginally higher because the lower-margin Powder drag is gone. That gives a normalised FY26 EBITDA somewhere in the Rs 480-540 cr band, before any JSW-led integration spend.
The cleanest cross-check is the 9M FY26 comparable EBITDA — the like-for-like figure that strips Powder Coatings and IRC out of the prior-year comparable base — which printed Rs 380.7 cr, down 9.7% YoY on Birla-driven pricing pressure rather than deal-driven distortion. Annualised, that’s roughly Rs 508 cr. The fourth quarter is seasonally the strongest in Indian paints, so the actual full-year number could land in a Rs 510-540 cr band. The quarterly read for Q3 FY26 itself was a useful illustration of the prose problem: reported revenue was down 13.6% YoY, comparable revenue was down only 1.0%, reported PAT was down 31.6%, comparable PAT was up 5.9%. The honest answer to which one to use is “neither, the entity has reset.”
The ROCE math, post-reset, will look strange. The slump-sale removed roughly Rs 3,295 cr of asset value gross, before the special-dividend distribution wrote down equity by another Rs 763 cr or so. Total assets that stood at about Rs 2,872 cr in March 2025 will probably print somewhere between Rs 2,000 and 2,200 cr at the post-distribution March 2026 close — actuals due in May 2026 will refine this. With EBIT in the continuing entity normalising to Rs 380-420 cr, the post-deal ROCE could optically expand into the high-30s or above 40% — higher than the historical print, which would set off a screen-based valuation tool with the wrong message. This is bookkeeping flattering, not moat improvement. The carve-out removed lower-returning assets and the dividend distribution shrank the denominator. The economic profitability of the continuing business has not, in any operational sense, gone up. Worth saying out loud, because at least one or two screener-driven take pieces will report this as good news.
Capex requirements are similarly subdued. The listco’s existing manufacturing footprint — 250 mn litres of decorative production capacity — is well-utilised and adequate for the next phase. The next capex cycle, if any, will more likely show up as brand investment, dealer-level infrastructure spend (tinting machines, sales training, distributor financing) and integration costs. That is operating-line spend, not balance-sheet capex.
What was paid, and what the buyer is exposed to
This is where the most rigorous bear line in the file lives. JSW paid 25x trailing EV/EBITDA for the carved-out continuing business. The continuing business’s actual run-rate EBITDA, as the 9M FY26 comparable suggests, is closer to Rs 510 cr full-year. At 25x, the implied EV is Rs 12,750 cr. The deal valued the entity at Rs 14,790 cr. The market is currently pricing it at Rs 13,322 cr, an implied share price of Rs 2,925 against the SPA reference of Rs 3,248 — a discount of about 10% to the deal price. The market, in other words, has marked the entity down roughly halfway from the deal price toward what 25x on the actual current EBITDA would support. The 25x multiple was the seller’s price. The buyer — and now the public minority that rides alongside the buyer — is exposed to the gap closing the wrong way if the carved-out business cannot grow into that multiple.
If you re-rate that gap rigorously: the historical P/E and ROCE of Akzo Nobel India were earned partly on a Powder Coatings B2B mix and a multinational-pedigree governance premium. Both of those have left the listco. The continuing decorative-only business, on its own, may not deserve a 25x multiple — particularly if Birla’s marketing intensity continues to compress sector margins through FY27. At a more realistic 18-20x EV/EBITDA for a #4 player without a clear margin moat, Rs 510 cr of EBITDA implies Rs 9,200-10,200 cr of EV — a 25-30% drop from the current price. This is the bear case that is mathematically the cleanest, even if it is not the most likely outcome. The market has marked it down 10% already. Another leg of 15-20% is the fair-value bear case if the buyer is now exposed to the seller’s price.
The minority shareholder question — three plausible endings
JSW now controls 61.2%. AkzoNobel NV retains 14.0% as a passive holder, expected to taper down over time through ordinary block trades. Public float is approximately 24.8% — a free float of roughly Rs 3,300 cr at current prices. That’s enough liquidity to avoid the microcap-discount problem but not enough to make this an index-relevant name. For a public minority shareholder reading this in April 2026, the relevant question is less “what does the FY29 DCF say” and more “where does this end up structurally”. There are three plausible endings, and the probabilities matter more than the precision.
The first, which I’d weight at roughly 40%, is status quo indefinitely. JSW keeps Dulux listed as a separate vehicle, runs JSW Paints Private alongside it, and at some future point — three to five years out — merges the private vehicle into the listco through a court-approved scheme of arrangement. The public minority gets to ride along with whatever value is created. The open-offer arithmetic supports this reading: JSW capped itself at 75% under the SEBI regime, which suggests no immediate delisting plan. The second, which I’d weight at about 35%, is the eventual merger of JSW Paints Private into the listco. Parth Jindal’s July 2025 “natural” comment is the most direct signal we have. If that happens, the swap ratio is the entire ballgame for minorities. JSW Paints Private is loss-making, growing slowly, and will be valued on a forward-multiple-of-revenue basis at whatever the merchant bankers and the Big Four valuer agree. The risk is that minorities of JSWDULUX get diluted into a larger but less profitable combined entity at a ratio that favours the JSW family. The protection — partial — is the SEBI scheme-of-arrangement requirement of majority-of-minority approval. The third, which I’d weight at about 25%, is eventual delisting via the reverse-book-build squeeze-out mechanism. If JSW concludes that the listed structure carries more friction than benefit — compliance overhead, public-float maintenance, the governance complication of the brand IP being licensed back from a third party (AkzoNobel NV) — they could attempt delisting. The reverse-book-build floor under SEBI rules is the highest of the 60-day VWAP, the negotiated price discovered in the book-build, and the book value, with the open-offer reference of Rs 3,231 still anchoring things. A realistic delisting offer would have to clear at Rs 3,650-3,800 to succeed — i.e., 25-30% above the current Rs 2,925. This is the asymmetric upside scenario for minorities, and it is the only realistic mechanism by which the public price snaps back to or above the SPA reference. JSW has given no signal this is the plan. The MOFSL “minority squeeze-out” commentary that has occasionally been referenced in informal circulation does not appear, on a careful search, to be a published research note — it reads more like desk colour. It belongs in the structural-possibility file, not the analyst-call file.
The honest summary: until JSW signals a path, the 10% public-market discount to the deal price is the structural-resolution question, not a mispricing.
How to model the next two years
Forecasting the listed entity in isolation gives the cleanest output, since that is what the public actually owns. FY26 revenue probably comes in at Rs 3,650-3,750 cr — flat to up 3% on the pro-forma post-carveout FY25 base of Rs 3,617 cr, given that 9M FY26 was down 1.0% comparable and Q4 typically rebuilds with seasonal strength and the new pricing actions. FY26 EBITDA at a 14% margin lands at Rs 510-540 cr. FY26 PAT excluding exceptionals is probably Rs 350-380 cr. FY27 — the first clean comparable year — should look like 8-10% growth on the JSW operational push, taking revenue to Rs 3,950-4,150 cr, EBITDA to Rs 560-620 cr at a 14-15% margin, and PAT to Rs 390-430 cr. The combined-vehicle picture — listco plus JSW Paints Private, if eventually merged — would put FY26 combined revenue at Rs 5,800-6,200 cr and combined EBITDA at Rs 480-540 cr (lower because the value vehicle drags the margin down). The three-year stretch case implied by JSW’s Rs 10,000 cr / #3 target requires a combined revenue CAGR of about 25% through FY29, with the listed entity contributing roughly Rs 5,000 cr of that. The probability that JSW gets to the full Rs 10,000 cr and the #3 spot is, on my read, 25-30%. The probability of Rs 7,500 cr combined and a #4 is 60-70%. The probability that the value half throws off meaningful EBITDA in any of these scenarios is harder — Indian decorative-paints value-tier is structurally lower-margin, and Birla is fighting for the same Tier-2/3 ground.
Where the standard sector lens breaks
The sector brief uses twelve comparable metrics. For Asian Paints, Berger and Indigo, those numbers are an honest snapshot of going concerns. For JSW Dulux they are mostly broken in three different ways at once. The historical FY25 numbers describe a different company — they include Powder Coatings, IRC, and a Dutch parent doing the capital allocation with a 106% dividend payout ratio that does not survive into FY27. The Q3 FY26 print straddles the deal close. And the valuation multiples are doing strange things at the same time — P/E TTM looks low because the trailing EPS is contaminated with about Rs 360 cr of exceptional gain from the slump-sale proceeds, EV/EBITDA looks low because the EBITDA in the denominator still reflects the divested-business contribution, and the capital structure is temporarily distorted by the special-dividend run-through. The lens that actually works for this name in this window is a combination of EV/Sales on the normalised post-carveout revenue base (the deal itself implied 4.0x sales: €1.4bn EV against Rs 3,617 cr of pro-forma FY25 revenue), an explicit SOTP framing that separates what the public minority actually owns (the listed liquid-paints entity, Dulux brand licensed) from what JSW Group owns alongside (JSW Paints Private, separate brand, separate balance sheet), and a structural-disposition view of where the entity ends up — kept listed indefinitely, merged with JSW Paints Private into JSWDULUX, or eventually delisted at what price. DCF precision in this name pretends to a knowledge of governance that the market does not yet have.
The twelve metrics, with explicit honesty about which numbers don’t carry forward:
| # | Metric | Value | Note |
|---|---|---|---|
| 1 | FY25 revenue (Rs cr) | 4,091.2 reported / 3,617 pro-forma post-carveout | year to Mar 2025 |
| 2 | 3-year revenue CAGR FY22→FY25 | 9.1% on reported (Rs 3,149 → Rs 4,091); pro-forma NM | — |
| 3 | Gross margin FY25 | NM forward; consolidated ~37-39% inferred | segment GM not disclosed |
| 4 | EBITDA margin FY25 (pre-exceptionals) | 13.6% consolidated; ~13.5-14.5% pro-forma | actuals visible FY26 |
| 5 | EBITDA margin trajectory | FY22 12.7% → FY23 12.3% → FY24 12.4% → FY25 13.6% → 9M FY26 comparable 13.9% | holding up better than peers |
| 6 | ROCE FY25 | 41.7% (screener.in) | NM forward — denominator shrinks |
| 7 | ROE FY25 | 32.2% | — |
| 8 | CFO/EBITDA FY25 | ~80-90% estimated | historical 75-95% band |
| 9 | Working capital days FY25 | ~30-40 days | decorative norm |
| 10 | Net debt/equity FY25 | net cash (Rs 62 cr borrowings vs Rs 1,329 cr equity) | deal financing at parent vehicle |
| 11 | P/E TTM | 35.7x screener / ~37x on normalised continuing PAT | TTM EPS distorted by exceptionals |
| 12 | EV/EBITDA TTM | 22-26x range | depends on how part-period treated |
Two extras the brief wants. Decorative revenue mix moves from 75-80% pre-carveout to 88-92% post-carveout, since liquid industrial and auto refinish are the only meaningful non-decorative segments retained. A&P spend as a percentage of revenue is not separately disclosed historically; the line-item evolution from FY24 to FY25 suggests A&P stepped up by roughly 80-100 basis points as Birla landed, broadly consistent with peer behaviour.
What changes my view
Five things would meaningfully shift the read. The Q4 FY26 print, due late April or early May 2026, will be the first clean look at the continuing-business margin profile and the operational stamp JSW is making. If margin holds at 14%-plus on Rs 1,100+ cr of quarterly revenue, the 25x deal multiple is defensible. Any signal on JSW Paints Private financials — if the standalone vehicle has stabilised at Rs 2,500-plus cr revenue with positive EBITDA in FY26 — strengthens the merged-entity case. A formal capital-allocation framework from Parth Jindal, of the kind JSW does not typically publish but which the market would weight heavily, would change confidence levels. Any indication of merger, delisting or buyback would crystallise the structure question one way or another. And Birla’s behaviour in the premium-urban tier matters as the external macro variable the listco can’t control — if Birla raises ad spend in premium emulsion in FY27 (their focus to date has been on mass-market emulsion), Dulux’s margin advantage erodes faster.
Where the analytical confidence is thinner
The gaps in this note are real, not stylistic. The formal CCI order text is not yet public — only the press release. The post-carveout pro-forma FY25 revenue of Rs 3,617 cr is a computed figure (Rs 4,091 reported less Rs 421 Powder less Rs 53.5 IRC); the actual restated FY25 numbers will appear in the FY26 annual report later in 2026 and may differ at the margins. JSW Paints Private FY25 financials are from a CARE Ratings press release rather than an audited statement; the “operating losses returned in FY25” line is rating-agency interpretation. The royalty and brand-licensing terms with AkzoNobel NV for Dulux IP have not been disclosed in detail — a 50-100 bps EBITDA-margin swing item that is, until the next annual report, a black box.
Bottom line
The orthodox lens fails honestly on this name. JSW Dulux is a 10% discount to a recently-paid private-market deal price in a continuing business that may or may not grow into the multiple at which the seller exited. It is a company in mid-reset; FY27 will be the first clean comparable year. It is a bet on JSW Group execution in a category where they have a mixed track record — the standalone JSW Paints private vehicle has not, in six years, sustained breakeven or hit half its own revenue target. The dual-brand productivity-per-dealer pitch is strategically sound but operationally unproven at JSW. Sajjan’s playbook of capital-heavy industrial scale does not perfectly translate to brand-and-distribution. And it is the cheapest paint name on P/E for reasons that are real — minority-shareholder structural risk, integration uncertainty, Dulux-as-licensed-brand governance complication.
For a holder of 100 shares already in the book, hold and re-evaluate after Q4 FY26 makes the most sense. The transaction reference price of Rs 3,248 is a soft floor that is likely, though not certain, to be revisited through corporate action — JSW will probably not let the listco trade well below the deal price indefinitely without doing something. A 15-20% return over twelve to eighteen months is the base-case path, combining ~10% recovery toward the deal mark with sector-rate operational growth. Topping up only makes sense if you carry a strong view on JSW operational execution and the eventual merger or delisting outcome referencing a price at or above the SPA. Selling is the right call if you owned this for the AkzoNobel pedigree, the multinational governance, and the Powder Coatings B2B mix, none of which the new entity has — in which case, take the Rs 167.5 special dividend that has already cleared, plus the open-offer-equivalent option, and recycle into something with a clearer story.
Not a high-conviction long, not a high-conviction short. A watch-the-next-two-quarterlies-and-let-the-structure-clarify name. The asymmetry on a delisting offer is the one thing that turns this into a top-up case. That signal is not yet visible.
Sources and dating
All numbers as of mid-to-late April 2026 unless explicitly older. Key sources: AkzoNobel NV press release on India sale completion (December 11, 2025, akzonobel.com); Akzo Nobel India BSE filings under AKZOINDIA — Q3 FY26 results January 2026, FY25 results May 2025 (bseindia.com); SEBI open-offer documentation, pre-offer advertisement October 2025, post-offer advertisement November 2025 (sebi.gov.in); CCI press release on acquisition approval (September 16, 2025; pib.gov.in / cci.gov.in); slump-sale announcement and pricing of Rs 2,143 cr Powder Coatings + IRC and Rs 1,152 cr brand IP, February 2025 (Outlook Business, Business Standard); JSW Paints private CARE Ratings press release (July 4, 2025); Parth Jindal interview, Business Standard, July 2025 (“merger logical”), retrieved via summary; Screener.in entry for AKZOINDIA / JSWDULUX (24 April 2026 retrieval); Multibagg.ai post-rebrand summary, March 2026; Q3 FY26 9-month commentary, Indian Chemical News and Investywise, January 2026.
Computed in this note: pro-forma post-carveout FY25 revenue (Rs 3,617 cr); SPA-implied 100% equity value (Rs 14,790 cr); SPA per-share price (Rs 3,248); discount of public price to SPA (10%); annualised FY26 EBITDA from 9M comparable (Rs 508 cr).
Less certain: gross margin (no segment-level disclosure); CFO/EBITDA (estimated); working-capital days (estimated); A&P spend (not separately disclosed); royalty terms with AkzoNobel NV for Dulux IP.